Publicaciones (19) Publicaciones de RAKEL LOPEZ DE MATURANA GARMENDIA

2018

  1. LRRK2 expression is deregulated in fibroblasts and neurons from parkinson patients with mutations in PINK1

    Molecular Neurobiology, Vol. 55, Núm. 1, pp. 506-516

  2. iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology

    Molecular Neurobiology, Vol. 55, Núm. 4, pp. 3033-3048

2016

  1. Mutations in LRRK2 impair NF-ΚB pathway in iPSC-derived neurons

    Journal of Neuroinflammation, Vol. 13, Núm. 1

2014

  1. Leucine-rich repeat kinase 2 modulates cyclooxygenase 2 and the inflammatory response in idiopathic and genetic Parkinson's disease

    Neurobiology of Aging, Vol. 35, Núm. 5, pp. 1116-1124

  2. Selection based on FOXA2 expression is not sufficient to enrich for dopamine neurons from human pluripotent stem cells

    Stem Cells Translational Medicine, Vol. 3, Núm. 9, pp. 1032-1042

  3. Sustained Increase of PKA Activity in the Postcommissural Putamen of Dyskinetic Monkeys

    Molecular Neurobiology, Vol. 50, Núm. 3, pp. 1131-1141

2013

  1. The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway

    Cellular and Molecular Life Sciences, Vol. 70, Núm. 1, pp. 121-136

2012

  1. The MAPK1/3 pathway is essential for the deregulation of autophagy observed in G2019S LRRK2 mutant fibroblasts

    Autophagy, Vol. 8, Núm. 10, pp. 1537-1539

2010

  1. Functional coupling of Cys-226 and Cys-296 in the glucagon-like peptide-1 (GLP-1) receptor indicates a disulfide bond that is close to the activation pocket

    Peptides, Vol. 31, Núm. 12, pp. 2289-2293

  2. Mecanismos implicados en la mejora cognitiva inducida por Rosiglitazona en un modelo animal de enfermedad de Alzheimer: XXXI Congreso Nacional de la SEF: póster premiado

    Actualidad en farmacología y terapéutica, Vol. 8, Núm. 1, pp. 71-74

  3. Regulation of corticostriatal synaptic plasticity by G protein-coupled receptors

    CNS and Neurological Disorders - Drug Targets, Vol. 9, Núm. 5, pp. 601-615

  4. Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: Mechanisms involving a reduced amyloid and tau pathology

    Neuropsychopharmacology, Vol. 35, Núm. 7, pp. 1593-1604

2009

  1. Early changes in hippocampal eph receptors precede the onset of memory decline in mouse models of alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 17, Núm. 4, pp. 773-786

  2. Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Aβ levels

    Neurobiology of Disease, Vol. 33, Núm. 3, pp. 369-378

2008

  1. Gonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth: Support for the concept of ligand-induced selective signaling

    Molecular Endocrinology, Vol. 22, Núm. 7, pp. 1711-1722

2007

  1. GnRH-mediated DAN production regulates the transcription of the GnRH receptor in gonadotrope cells

    NeuroMolecular Medicine, Vol. 9, Núm. 3, pp. 230-248

  2. Peptide binding at the GLP-1 receptor

    Biochemical Society Transactions

2006

  1. Gonadotropin-releasing hormone functionally antagonizes testosterone activation of the human androgen receptor in prostate cells through focal adhesion complexes involving Hic-5

    Neuroendocrinology, Vol. 84, Núm. 5, pp. 285-300

2005

  1. Class II G protein-coupled receptors and their ligands in neuronal function and protection

    NeuroMolecular Medicine, Vol. 7, Núm. 1-2, pp. 3-36